Addendum to the 2023 clinical practice guidelines for amyotrophic lateral sclerosis in Japan: approval and integration of novel disease-modifying therapies
- DOI
- 10.5692/clinicalneurol.cn-002198
- Published
- 2026
- Container
- Rinsho Shinkeigaku
- Publisher
- Societas Neurologica Japonica
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.5692/clinicalneurol.cn-002198,
title = {Addendum to the 2023 clinical practice guidelines for amyotrophic lateral sclerosis in Japan: approval and integration of novel disease-modifying therapies},
author = {Hitoshi Warita and Makoto Urushitani and Naoki Atsuta and Yuishin Izumi and Osamu Kano and Toshio Shimizu and Yuki Nakayama and Yugo Narita and Hiroyuki Nodera and Takuji Fujita and Koichi Mizoguchi and Mitsuya Morita and Masashi Aoki},
year = {2026},
journal = {Rinsho Shinkeigaku},
doi = {10.5692/clinicalneurol.cn-002198},
url = {https://doi.org/10.5692/clinicalneurol.cn-002198}
}RIS
TY - JOUR TI - Addendum to the 2023 clinical practice guidelines for amyotrophic lateral sclerosis in Japan: approval and integration of novel disease-modifying therapies AU - Hitoshi Warita AU - Makoto Urushitani AU - Naoki Atsuta AU - Yuishin Izumi AU - Osamu Kano AU - Toshio Shimizu AU - Yuki Nakayama AU - Yugo Narita AU - Hiroyuki Nodera AU - Takuji Fujita AU - Koichi Mizoguchi AU - Mitsuya Morita AU - Masashi Aoki PY - 2026 JO - Rinsho Shinkeigaku DO - 10.5692/clinicalneurol.cn-002198 UR - https://doi.org/10.5692/clinicalneurol.cn-002198 ER -
APA
Warita, H., Urushitani, M., Atsuta, N., Izumi, Y., Kano, O., Shimizu, T., Nakayama, Y., Narita, Y., Nodera, H., Fujita, T., Mizoguchi, K., Morita, M., & Aoki, M. (2026). Addendum to the 2023 clinical practice guidelines for amyotrophic lateral sclerosis in Japan: approval and integration of novel disease-modifying therapies. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.cn-002198
Source records
- crossref · retrieved 2026-09-26T21:26:48.313Z